REVESTIVE

This brand name is authorized in Austria, Australia, Brazil, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Japan, Lithuania, New Zealand, Poland, Romania, United Kingdom

Active ingredients

The drug REVESTIVE contains one active pharmaceutical ingredient (API):

1 Teduglutide UNII 7M19191IKG - TEDUGLUTIDE

Teduglutide is an analogue of GLP-2. The naturally occurring human glucagon-like peptide-2 (GLP-2) is a peptide secreted by L cells of the intestine which is known to increase intestinal and portal blood flow, inhibit gastric acid secretion, and decrease intestinal motility. In several nonclinical studies, teduglutide has been shown to preserve mucosal integrity by promoting repair and normal growth of the intestine through an increase of villus height and crypt depth. Read about Teduglutide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
REVESTIVE 1.25 mg Powder and solvent for solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC
REVESTIVE 5 mg Powder and solvent for solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A16AX08	Teduglutide	A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AX Various alimentary tract and metabolism products
Discover more medicines within A16AX08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11793Q, 11794R, 11795T, 11806J, 11808L, 11812Q
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501121030037917, 540219040004301
Country: CA	Health Products and Food Branch	Identifier(s): 02445727
Country: EE	Ravimiamet	Identifier(s): 1593233, 1748842, 1788475
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 12787001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 158153, 463088
Country: FR	Base de données publique des médicaments	Identifier(s): 63112361, 64929099
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 279480, 350845
Country: IE	Health Products Regulatory Authority	Identifier(s): 89043, 89044
Country: IT	Agenzia del Farmaco	Identifier(s): 045578010, 045578034
Country: JP	医薬品医療機器総合機構	Identifier(s): 2499419D1026, 24994A7D1027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1067357, 1083719, 1083720
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 19238
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100315864, 100417903
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68911001, W68912001, W68912002